Ticagrelor 90mg Tablet
Ticagrelor is indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) (unstable angina, non-ST elevation myocardial infarction, or ST elevation myocardial infarction). It has been shown to reduce the rate of cardiovascular death, myocardial infarction or stroke compared to clopidogrel. In patients treated with PCI, it also reduces the rate of stent thrombosis.
Ticagrelor 90mg Tablet
Ticagrelor is indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) (unstable angina, non-ST elevation myocardial infarction, or ST elevation myocardial infarction). It has been shown to reduce the rate of cardiovascular death, myocardial infarction or stroke compared to clopidogrel. In patients treated with PCI, it also reduces the rate of stent thrombosis.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.